Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Equity (2016 - 2025)

Ocular Therapeutix (OCUL) has 12 years of Return on Equity data on record, last reported at 0.58% in Q4 2025.

  • For Q4 2025, Return on Equity fell 8.0% year-over-year to 0.58%; the TTM value through Dec 2025 reached 0.58%, down 8.0%, while the annual FY2025 figure was 0.54%, 27.0% up from the prior year.
  • Return on Equity reached 0.58% in Q4 2025 per OCUL's latest filing, up from 0.88% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.3% in Q2 2024 and bottomed at 16.05% in Q3 2023.
  • Average Return on Equity over 5 years is 2.49%, with a median of 0.94% recorded in 2021.
  • The widest YoY moves for Return on Equity: up 12445bps in 2021, down -3296bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.97% in 2021, then tumbled by -115bps to 2.08% in 2022, then grew by 13bps to 1.81% in 2023, then surged by 73bps to 0.49% in 2024, then dropped by -17bps to 0.58% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.58% in Q4 2025, 0.88% in Q3 2025, and 0.78% in Q2 2025.